CAMP4 Therapeutics Corpor... (CAMP)
NASDAQ: CAMP
· Real-Time Price · USD
2.98
-0.02 (-0.67%)
At close: Sep 26, 2025, 3:59 PM
2.93
-1.68%
After-hours: Sep 26, 2025, 07:26 PM EDT
CAMP4 Therapeutics Revenue Breakdown
| Period Ending | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 | Aug 31, 2020 | May 31, 2020 | Nov 30, 2019 | Aug 31, 2019 | May 31, 2019 | Feb 28, 2019 | Nov 30, 2018 | Aug 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Application Subscriptions And Other Services Revenue | 22.42M | 24.39M | 24.59M | 28.05M | 25.56M | 27.13M | 25.33M | 29.36M | 28.4M | 27.48M | 27.68M | 25.71M | 29.68M | 32.59M | 27.11M | 63.19M | 62.03M | 63.56M | 64.42M | 67.57M | 76.97M |
| Application Subscriptions And Other Services Revenue Growth | -8.07% | -0.83% | -12.31% | +9.73% | -5.81% | +7.12% | -13.73% | +3.39% | +3.34% | -0.70% | +7.64% | -13.38% | -8.92% | +20.23% | -57.10% | +1.87% | -2.40% | -1.34% | -4.66% | -12.22% | n/a |
| Product Revenue | 31.2M | 37.33M | 46.3M | 50.46M | 53.33M | 45.69M | 39.4M | 39.01M | 40.38M | 51.53M | 52M | 31.11M | 58.33M | 50.94M | 53.11M | n/a | n/a | n/a | n/a | n/a | n/a |
| Product Revenue Growth | -16.40% | -19.38% | -8.25% | -5.38% | +16.71% | +15.99% | +0.98% | -3.37% | -21.64% | -0.90% | +67.14% | -46.66% | +14.49% | -4.07% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 | Aug 31, 2020 | May 31, 2020 | Feb 29, 2020 | Nov 30, 2019 | Aug 31, 2019 | May 31, 2019 | Feb 28, 2019 | Nov 30, 2018 | Aug 31, 2018 | May 31, 2018 | Feb 28, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Other Revenue | 1.51M | 2.39M | 1.23M | 1.43M | 1.78M | 534K | 589K | 444K | 770K | 1.39M | 2.07M | 1.98M | 2.04M | 1.66M | 4.38M | -2.24M | 5.49M | 2.61M | 3.79M | -4.25M | 3.53M | 4.06M | 1.84M | -4.14M |
| All Other Revenue Growth | -36.77% | +93.83% | -13.54% | -19.85% | +232.96% | -9.34% | +32.66% | -42.34% | -44.76% | -32.75% | +4.49% | -2.51% | +22.30% | -61.99% | -295.62% | -140.74% | +110.82% | -31.26% | -189.24% | -220.24% | -13.00% | +121.07% | -144.33% | n/a |
| Asia Pacific Revenue | 4.82M | 7.64M | 6.16M | 4.85M | 2.79M | 5.59M | 5.22M | 3.49M | 5.76M | 2.79M | 5.4M | 4.2M | 4.03M | 1.7M | 2.34M | 1.77M | 3.04M | 1.94M | 2.41M | 3.25M | 3.46M | 3.48M | 3.76M | 3.28M |
| Asia Pacific Revenue Growth | -36.91% | +24.14% | +27.01% | +73.48% | -50.02% | +7.11% | +49.37% | -39.34% | +106.16% | -48.27% | +28.47% | +4.21% | +136.74% | -27.15% | +32.00% | -41.79% | +56.91% | -19.47% | -25.97% | -6.09% | -0.43% | -7.42% | +14.60% | n/a |
| Emea Revenue | 14.22M | 13.85M | 7.1M | 8.83M | 9.01M | 8.19M | 5.98M | 47.05M | n/a | n/a | 51.2M | 29.35M | 60.82M | 58.95M | 51.55M | 64.73M | 1.04M | 4.23M | 3.49M | 60.3M | 67.09M | 70.65M | 70.42M | 68.43M |
| Emea Revenue Growth | +2.72% | +95.08% | -19.64% | -1.98% | +10.04% | +37.01% | -87.30% | n/a | n/a | n/a | +74.46% | -51.75% | +3.19% | +14.35% | -20.37% | +6100.67% | -75.30% | +21.26% | -94.22% | -10.12% | -5.04% | +0.33% | +2.91% | n/a |
| Latin America Revenue | 3.87M | 5.25M | 39.4M | 48.44M | 50.39M | 46.24M | 40.4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 69.96M | 68.68M | 63.12M | n/a | n/a | n/a | n/a | n/a |
| Latin America Revenue Growth | -26.33% | -86.67% | -18.66% | -3.87% | +8.97% | +14.45% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | +1.86% | +8.81% | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue | 29.2M | 32.59M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | -10.39% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 | Aug 31, 2020 | May 31, 2020 | Feb 29, 2020 | Nov 30, 2019 | Aug 31, 2019 | May 31, 2019 | Feb 28, 2019 | Nov 30, 2018 | Aug 31, 2018 | May 31, 2018 | Feb 28, 2018 | Nov 30, 2017 | Aug 31, 2017 | May 31, 2017 | Feb 28, 2017 | Nov 30, 2016 | Aug 31, 2016 | May 31, 2016 | Feb 29, 2016 | Nov 30, 2015 | Aug 31, 2015 | May 31, 2015 | Feb 28, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.18M | 3.81M | 4.69M | 3.81M | 3.27M | 3.13M | 19M | 19.63M | 22.38M | 22.65M | 23.66M | 26.26M | 26.64M | 24.49M | 26.01M | 25.25M | 25.15M | 25.63M | 28.29M | 27.39M | 26.55M | 28.34M | 28.97M | 28.76M | 32.13M | 6.05M | 24.46M | 24.51M | 25.93M | 25.86M | 23.97M | 23.27M | 29.08M | 29.52M | 24.17M | 23.97M | 27.29M | 16.24M | 11.18M | 10.76M | 10.27M | 9.23M |
| Selling, General, and Administrative Revenue Growth | +9.71% | -18.72% | +22.97% | +16.53% | +4.40% | -83.50% | -3.23% | -12.27% | -1.19% | -4.28% | -9.92% | -1.41% | +8.78% | -5.86% | +3.05% | +0.39% | -1.89% | -9.39% | +3.27% | +3.15% | -6.32% | -2.14% | +0.71% | -10.49% | +431.09% | -75.27% | -0.20% | -5.47% | +0.29% | +7.86% | +3.02% | -19.98% | -1.48% | +22.12% | +0.85% | -12.18% | +68.05% | +45.30% | +3.92% | +4.69% | +11.29% | n/a |
| Research and Development Revenue | 10.34M | 10.15M | 10M | 9.7M | 9.56M | 9.74M | 4.05M | 4.8M | 5.84M | 5.33M | 5.48M | 6.76M | 7M | 6.6M | 7.18M | 7.73M | 6.94M | 6.89M | 6.78M | 6.99M | 6.32M | 6.88M | 7.74M | 7.92M | 6.89M | 6.28M | 7.18M | 7.6M | 6.6M | 6.91M | 6.3M | 6.72M | 5.83M | 4.73M | 5.3M | 5.88M | 6.09M | 5.12M | 5.12M | 5M | 4.57M | 4.87M |
| Research and Development Revenue Growth | +1.94% | +1.50% | +3.03% | +1.44% | -1.80% | +140.43% | -15.60% | -17.84% | +9.52% | -2.65% | -18.91% | -3.47% | +6.12% | -8.12% | -7.12% | +11.37% | +0.78% | +1.52% | -2.95% | +10.52% | -8.13% | -11.08% | -2.30% | +15.07% | +9.67% | -12.51% | -5.55% | +15.12% | -4.44% | +9.72% | -6.38% | +15.31% | +23.25% | -10.67% | -9.99% | -3.38% | +18.92% | +0.02% | +2.52% | +9.42% | -6.22% | n/a |